Cala TAPS™ Therapy Reduces Hand Tremor – Essential Tremor Study
- This article details new research supporting the effectiveness of Cala TAPS™ therapy, a non-invasive treatment for essential tremor (ET) and Parkinson's disease tremor.Here's a breakdown of the key...
- * Mechanism of Action Confirmed: Studies demonstrate that TAPS™ therapy directly modulates neural activity in the brain, specifically influencing the ventral intermediate (VIM) nucleus of the thalamus -...
- In essence,the research validates that Cala TAPS™ therapy isn't just masking symptoms,but actively impacting the brain mechanisms responsible for tremor.
Summary of Cala TAPS™ Therapy Research
This article details new research supporting the effectiveness of Cala TAPS™ therapy, a non-invasive treatment for essential tremor (ET) and Parkinson’s disease tremor.Here’s a breakdown of the key findings:
* Mechanism of Action Confirmed: Studies demonstrate that TAPS™ therapy directly modulates neural activity in the brain, specifically influencing the ventral intermediate (VIM) nucleus of the thalamus – a key target for more invasive treatments like deep brain stimulation (DBS).
* Brain Wave Correlation: Tremor reduction with TAPS™ therapy is linked to changes in alpha and beta brain wave activity within the VIM, aligning with optimal DBS lead placement locations.
* Metabolic Changes: PET imaging showed that TAPS™ therapy leads to decreased tremor symptoms and changes in metabolic activity in brain areas involved in tremor circuitry, including the cerebellum. this suggests a durable effect on underlying brain networks.
* Positive Clinical Outcomes: Researchers and clinicians report significant tremor reduction and improved daily function in patients using TAPS™ therapy.
* Accessibility: The Cala system is available at no cost to eligible veterans through the VA Health System and has Medicare coverage for qualifying patients.
In essence,the research validates that Cala TAPS™ therapy isn’t just masking symptoms,but actively impacting the brain mechanisms responsible for tremor. This positions it as a potentially paradigm-shifting treatment for ET and Parkinson’s disease tremor.
